Market Overview

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)

170.53 +2.02 (1.20%)

Analyst Ratings

DateResearch FirmActionCurrentPT
4/12/19Initiates Coverage OnIn-Line
3/26/19UpgradesOutperform
3/19/19DowngradesMarket Perform
3/07/19MaintainsOutperform230.0
1/04/19MaintainsBuy205.0
1/02/19DowngradesMarket Perform
12/19/18MaintainsOverweight210.0
12/18/18ReinstatesNeutral
10/26/18UpgradesBuy220.0
10/25/18MaintainsOutperform201.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter